ストックスクリーナーアプリを入手
5.08
7.17%
0.34
アフターアワーズ：
5.08
前日終値:
$4.74
開ける：
$4.71
24時間の取引高:
478.14K
Relative Volume:
1.42
時価総額：
$305.33M
収益：
$32.72M
当期純損益:
$-54.64M
株価収益率:
-4.5047
EPS:
-1.1277
ネットキャッシュフロー:
$-55.08M
1週間 パフォーマンス:
-2.03%
1か月 パフォーマンス:
+18.97%
6か月 パフォーマンス:
+11.40%
1年 パフォーマンス:
+85.40%
1日の値動き範囲:
$4.71
$5.14
1週間の範囲:
$4.71
$5.3492
52週間の値動き範囲:
$2.20
$5.78
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
5.08 | 326.37M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | 開始されました | TD Cowen | Buy |
| 2025-08-20 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-03-20 | 開始されました | BTIG Research | Buy |
| 2025-01-02 | 開始されました | Barclays | Overweight |
| 2024-08-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | B. Riley Securities | Buy |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan
Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan
Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan
Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan
Orchestra BioMed (OBIO) Holds Gains at $4.45, Consolidating Between Key Technical LevelsComposite Profile - vinanet.vn
Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st
Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Raises Target Price to $10 - Moomoo
Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView
Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Investing News Network
OBIO Looks 87.4% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Orchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Orchestra BioMed Reports Q2 2026 Results and Updates Progress on BACKBEAT and Virtue Pivotal Trials - Moomoo
Orchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock Titan
Orchestra BioMed (OBIO) Climbs 1.56% to $4.31 as Shares Hold Above Key SupportLast Point Support - vinanet.vn
Orchestra Biomed Holdings Inc (OBIO) Stock News Today - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra BioMed (OBIO) Insider Darren Sherman Sells 15,000 Shar - GuruFocus
Darren Sherman Sells 15,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock - marketbeat.com
Orchestra BioMed (OBIO) insider sale under 10b5-1 plan on August 3, 2026 - Stock Titan
Orchestra BioMed (OBIO) Projected to Announce Quarterly Earnings on Tuesday - marketbeat.com
Orchestra BioMed (NASDAQ: OBIO) insider details Rule 144 sales of 45,000 shares - Stock Titan
Orchestra BioMed (OBIO) Holds Near $4.00 as Shares Test Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Orchestra Biomed Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
OBIO|Orchestra Biomed Holdings Inc|Price:3.825|Chg%:+0.085 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Income Statement - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Balance Sheet - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orchestra BioMed Holdings, Inc. Revenue Breakdown – NASDAQ:OBIO - TradingView
Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
OBIO|Orchestra Biomed Holdings Inc|Price:3.980|Chg%:-0.010 - TradingKey
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss as Pre-Revenue Biotech Advances PipelineHealthcare Earnings Report - po-news-eg.net
Orchestra Biomed Holdings Inc - TradingKey
Orchestra BioMed (OBIO) Bounces 2.75% as Traders Eye Key Resistance at $3.93Rounding Bottom - dars.gov.et
Orchestra Biomed Holdings Inc (OBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orchestra BioMed Hldgs Market Sentiment - Benzinga
TradingKey - TradingKey
OBIO|Orchestra Biomed Holdings Inc|Price:3.740|Chg%:+0.100 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
Orchestra Biomed Holdings Inc (OBIO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sherman Darren | See Remarks |
Aug 03 '26 |
Sale |
4.09 |
15,000 |
61,350 |
1,154,327 |
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):